Kyu-Don Kim
Corporate Officer/Principal at GENEXINE, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Young-Chul Sung | M | 68 | 25 years | |
| Yu-Seok Seo | M | 54 | - | |
| Seong-Gi Baek | M | 75 | - | |
| Peter N. Laivins | M | 66 | - | |
| Jin-Geon Bae | M | 72 | - | |
| Mi-Jung Ahn | M | 62 | - | |
| Tae-Yong Lee | M | 64 | - | |
| Sie Djohan | M | 56 |
PT Kalbe Genexine Biologics
 PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | - |
| Young-Jin Kim | M | 67 | 9 years | |
| Vidjongtius | M | 59 |
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | - |
| Hyi-Jeong Ji | M | 65 | - | |
| Bernadus Karmin Winata | M | 59 |
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | - |
| Yong-MIn Won | M | 61 | - | |
| Bujung Nugroho | M | 60 |
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | - |
| Gwang-Ho Kim | M | 61 | - | |
| Jung-Won Woo | M | 64 | 3 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| South Korea | 12 | 75.00% |
| Indonesia | 4 | 25.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kyu-Don Kim
- Personal Network
